ACC 2011: One-year Absorb data positive; US approval in 2015?
This article was originally published in Clinica
Executive Summary
Full one-year data from the primary trial of Abbott's Absorb bioresorbable drug-eluting stent (DES) show the device to be safe and effective, adding to earlier data. The positive outcome should foreshadow the device's approval in the US, which may happen in four years.